There are 2949 resources available
363O - Clinical characterization of a real-life cohort of 6001 patients with brain metastases from solid cancers treated between 1986-2020
Presenter: Ariane Steindl
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
364O - Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases
Presenter: Thomas John
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
981O - Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial
Presenter: Ming Shi
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
LBA65 - The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)
Presenter: Daniel Renouf
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
1525O - The QOLIXANE trial - Real life QoL and efficacy data in 1st line pancreatic cancer from the prospective platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry
Presenter: Thorsten Götze
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
361O - Defining the prognostic role of MGMT methylation value by pyrosequencing assay in glioblastoma patients: A large Italian multicenter study
Presenter: Mario Caccese
Session: Proffered Paper - CNS tumours
Resources:
Abstract
Slides
Webcast
LBA11 - IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC)
Presenter: Nadia Harbeck
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
159O - Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the PARADIGM study group
Presenter: Vincent De Jong
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Webcast
160O - Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer, TNBC) (PM(Cb)) for patients (pts) with high-risk early breast cancer (BC)
Presenter: Andreas Schneeweiss
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Use of biomarkers in immunotherapy and the nursing role
Presenter: Sara Colomer-Lahiguera
Session: EONS13: Immunotherapy and precision oncology: What do patients need?
Resources:
Slides
Webcast